Meningococcal disease from the public health policy perspective

Vaccine

Volumn 30, Issue SUPPL. 2, 2012, Pages

  Black, Steven B ^a   Plotkin, Stanley A ^b,c  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Vaxconsult   (United States)

Author keywords

Meningococcal; Public policy; Vaccine

Indexed keywords

MENINGOCOCCUS VACCINE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; GEOGRAPHIC DISTRIBUTION; HEALTH CARE POLICY; HUMAN; IMMUNIZATION; INCIDENCE; MENINGOCOCCOSIS; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PUBLIC HEALTH; TREATMENT OUTCOME; VACCINATION;

HEALTH POLICY; HUMANS; IMMUNIZATION SCHEDULE; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; PUBLIC HEALTH ADMINISTRATION; UNITED STATES; VACCINATION;

EID: 84861133636     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.12.074     Document Type: Article

References (12)

1. Bilukha O.O., Rosenstein N. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2005, 54(RR-7):1-21.
2. World Health Organization Fact sheet: meningococcal meningitis 2003, http://www.who.int/mediacentre/factsheets/fs141/en/print.html [accessed 09.12.09].
3. Harrison L.H., Trotter C.L., Ramsay M.E. Global epidemiology of meningococcal disease. Vaccine 2009, 27(Suppl 2):B51-B63.
4. [accessed 04.10.11]. http://www.cdc.gov/vaccines/recs/ACIP/slides-oct09.htm%23mv.
5. EU-IBIS Network. Invasive meningococcal disease in Europe. London 2007: Health Protection Agency; 2006.
6. [accessed 04.10.11]. http://www.cdc.gov/print.do%3Furl=http%3A//www.cdc.gov/vaccines/vpd-vac/mening/vac-mening-fs.htm.
7. Khatami A., Pollard A.J. The epidemiology of meningococcal disease and the impact of vaccines. Expert Rev Vaccines 2010, 9:285-298.
8. Rosenstein N.E., Perkins B.A., Stephens D.S., Popovic T., Hughes J.M. Meningococcal disease. N Engl J Med 2001, 344(18):1378-1388.
9. Centers for Disease Control and Prevention (CDC) Factsheet: meningococcal diseases and meningococcal vaccines 2009, http://www.cdc.gov/print.do?url=http://www.cdc.gov/vaccines/vpd-vac/mening/vac-mening-fs.htm [accessed 28.08.11].
10. Blanchard-Rohner G., Pollard A.J. Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy. Expert Rev Vaccines 2011, 10:673-684.
11. Cohn A.C., MacNeil J.R., Harrison L., Hatcher C., Theodore J., Schmidt M., et al. Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease. Clin Infect Dis 2010, 50:184-191.
12. Shepard C.W., Ortega-Sanchez I.R., Douglas Scott I.I.R., Rosenstein N.E. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States. Pediatrics 2005, 115:1220-1232.